KMX.NYSECarmax INC

Form 4: CarMax SVP & Chief Product Officer Tyler Tuite Reports Stock Option Exercise and Sale

Sentiment:

SEC Form 4


Tyler Tuite, SVP & Chief Product Officer of CarMax, exercised stock options and sold shares on January 28, 2025.

Summary

  • On January 28, 2025, Tyler Tuite, SVP & Chief Product Officer of CarMax, exercised stock options to acquire 4,869 shares of common stock at a price of $78.61 per share.
  • Simultaneously, Tuite sold 4,869 shares of CarMax common stock at an average price of $84.58, with prices ranging from $84.54 to $84.59.
  • Following these transactions, Tuite directly owns 227 shares of CarMax common stock.
  • Tuite also continues to hold stock options.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing, so the sentiment is neutral.

Industry Context

This Form 4 filing is a routine disclosure of insider transactions, providing transparency into the trading activities of CarMax executives. It's common for executives to exercise stock options and sell a portion of the acquired shares for personal financial management.

Key Dates

DateDescription
05/01/2020Stock options became exercisable with respect to one-fourth of the underlying shares.
05/01/2021Stock options became exercisable with respect to one-fourth of the underlying shares.
05/01/2022Stock options became exercisable with respect to one-fourth of the underlying shares.
05/01/2023Stock options became fully exercisable.
01/28/2025Tyler Tuite exercised stock options and sold shares of CarMax common stock.
01/30/2025Date of signature by attorney-in-fact.
05/01/2026Expiration date of the stock options.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.